Rapport Therapeutics (NASDAQ:RAPP) Shares Bought by GAMMA Investing LLC
GAMMA Investing LLC grew its position in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 91,980.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,208 shares of the company’s stock after buying an additional 9,198 shares during the quarter. GAMMA Investing LLC’s […]
GAMMA Investing LLC grew its position in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 91,980.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,208 shares of the company’s stock after buying an additional 9,198 shares during the quarter. GAMMA Investing LLC’s […]
